Edwards J - Search Results

1

A novel androgen receptor splice variant is up-regulated during prostate cancer progression and promotes androgen depletion-resistant growth.

Guo Z, Yang X, Sun F, Jiang R, Linn DE, Chen H, Chen H, Kong X, Melamed J, Tepper CG, Kung HJ, Brodie AM, Edwards J, Qiu Y. Guo Z, et al. Among authors: edwards j. Cancer Res. 2009 Mar 15;69(6):2305-13. doi: 10.1158/0008-5472.CAN-08-3795. Epub 2009 Feb 24. Cancer Res. 2009. PMID: 19244107 Free PMC article.

2

Gene amplifications associated with the development of hormone-resistant prostate cancer.

Edwards J, Krishna NS, Witton CJ, Bartlett JM. Edwards J, et al. Clin Cancer Res. 2003 Nov 1;9(14):5271-81. Clin Cancer Res. 2003. PMID: 14614009

3

The role of HER1-HER4 and EGFRvIII in hormone-refractory prostate cancer.

Edwards J, Traynor P, Munro AF, Pirret CF, Dunne B, Bartlett JM. Edwards J, et al. Clin Cancer Res. 2006 Jan 1;12(1):123-30. doi: 10.1158/1078-0432.CCR-05-1445. Clin Cancer Res. 2006. PMID: 16397033 Free article.

4

Bad expression influences time to androgen escape in prostate cancer.

Teo K, Gemmell L, Mukherjee R, Traynor P, Edwards J. Teo K, et al. Among authors: edwards j. BJU Int. 2007 Sep;100(3):691-6. doi: 10.1111/j.1464-410X.2007.07001.x. Epub 2007 Jun 2. BJU Int. 2007. PMID: 17542986

5

SRC family kinase activity is up-regulated in hormone-refractory prostate cancer.

Tatarov O, Mitchell TJ, Seywright M, Leung HY, Brunton VG, Edwards J. Tatarov O, et al. Among authors: edwards j. Clin Cancer Res. 2009 May 15;15(10):3540-9. doi: 10.1158/1078-0432.CCR-08-1857. Epub 2009 May 15. Clin Cancer Res. 2009. PMID: 19447874 Free article.

6

GRP78 up-regulation is associated with androgen receptor status, Hsp70-Hsp90 client proteins and castrate-resistant prostate cancer.

Tan SS, Ahmad I, Bennett HL, Singh L, Nixon C, Seywright M, Barnetson RJ, Edwards J, Leung HY. Tan SS, et al. Among authors: edwards j. J Pathol. 2011 Jan;223(1):81-7. doi: 10.1002/path.2795. Epub 2010 Oct 28. J Pathol. 2011. PMID: 21125667

7

Expression of hypoxia inducible factor-1 alpha in matched hormone naive and castrate resistant prostate cancer specimens.

Elsberger B, Lankston L, Orange C, Underwood MA, Edwards J. Elsberger B, et al. Among authors: edwards j. Cancer Biomark. 2010-2011;8(1):1-9. doi: 10.3233/DMA-2011-0805. Cancer Biomark. 2010. PMID: 21896985

8

The bodies fight against cancer: is human leucocyte antigen (HLA) class 1 the key?

Powell AG, Horgan PG, Edwards J. Powell AG, et al. Among authors: edwards j. J Cancer Res Clin Oncol. 2012 May;138(5):723-8. doi: 10.1007/s00432-012-1192-4. Epub 2012 Mar 18. J Cancer Res Clin Oncol. 2012. PMID: 22426959 Review.

9

Tumoral C-reactive protein and nuclear factor kappa-B expression are associated with clinical outcome in patients with prostate cancer.

McCall P, Catlow J, McArdle PA, McMillan DC, Edwards J. McCall P, et al. Among authors: edwards j. Cancer Biomark. 2011-2012;10(2):91-9. doi: 10.3233/CBM-2012-0236. Cancer Biomark. 2011. PMID: 22430136

10

Distinct transcriptional programs mediated by the ligand-dependent full-length androgen receptor and its splice variants in castration-resistant prostate cancer.

Hu R, Lu C, Mostaghel EA, Yegnasubramanian S, Gurel M, Tannahill C, Edwards J, Isaacs WB, Nelson PS, Bluemn E, Plymate SR, Luo J. Hu R, et al. Among authors: edwards j. Cancer Res. 2012 Jul 15;72(14):3457-62. doi: 10.1158/0008-5472.CAN-11-3892. Epub 2012 Jun 18. Cancer Res. 2012. PMID: 22710436 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,150 results

Search Page

Filters